Pharma & Biotech
You will receive alerts when there are new announcements on Allergy Therapeutics PLC
Only registered members can use this feature.
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.
The broker now expects profits to around £5m higher than its previous forecasts at £2.9m.
© Proactive Investors 2020.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.